Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy

Curr Rheumatol Rep. 2002 Apr;4(2):179-85. doi: 10.1007/s11926-002-0014-0.

Abstract

A frequent manifestation of severe primary hyperparathyroidism was the bone disease osteitis fibrosa cystica. Rarely, excess parathyroid hormone (PTH) was associated with gout and calcium pyrophosphate crystal deposition disease. Surgical cure of primary hyperparathyroidism was occasionally associated with pseudogout. Today, primary hyperparathyroidism is generally asymptomatic. Clinically overt rheumatologic and skeletal effects are mainly of historical interest. Skeletal disease is still detectable by more sensitive techniques. In certain circumstances, PTH may be protective and anabolic for the skeleton.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Bone Diseases
  • Chondrocalcinosis
  • Gout
  • Humans
  • Hyperparathyroidism / complications*
  • Hyperparathyroidism / drug therapy*
  • Parathyroid Hormone / therapeutic use*

Substances

  • Parathyroid Hormone